Appeal No. 2003-1126 Page 3 Application No. 08/444,285 therewith, thereby obtaining a genetically transformed zygote; (ii) transplanting an embryo from the genetically transformed zygote into a psuedopregnant female; and (iii) allowing the embryo to develop to term; where said gene and control sequence are selected so that the gene is not activated in such a manner and degree as would prevent normal development of the embryo to term; and said polypeptide or protein is producible in a cell of said mammal which bears said gene, as a result of the expression of said gene under the control of said control sequence, and where said mammal, absent said exogenous genetic material is unable to produce said polypeptide or protein; and (b) expressing said gene in said mammal, or progeny thereof which retain said gene in expressible form, thereby producing said polypeptide or protein at a detectable level, where said mammal is selected from the group consisting of rodents, rabbits, goats, pigs, cattle, and sheep. The examiner relies upon the following references: Strojek et al. (Strojek), “The use of transgenic animal techniques for livestock improvement,” Genetic Engineering: Principles and methods, Vol. 10, pp. 221-246 (1988) Kappel et al. (Kappel), “Regulating gene expression in transgenic animals,” Current Opinion in Biotechnology, Vol. 3, pp. 548-553 (1992) Houdebine, “Production of pharmaceutical proteins from transgenic animals,” Journal of Biotechnology, Vol. 34, pp. 269-287 (1994) Wall, “Transgenic livestock: Progress and prospects for the future,” Theriogenology, Vol. 45, pp. 57-68 (1996) Claims 39, 41, 43, 45, 50, 51, 55-79, 82, 83, 86-114, 116 and 119 stand rejected under the judicially created obviousness-type double-patenting as being unpatentable over claims 1-7 of U.S. Patent No. 4,873,191. Claims 39, 41, 43, 45, 50, 51, 55-79, 82, 83, 86-114, 116 and 119 also stand rejected under 35 U.S.C. § 112, first paragraph, on the grounds that the specification fails to enablePage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 NextLast modified: November 3, 2007